Novoprotein Scientific Inc. (SHA:688137)
China · Delayed Price · Currency is CNY 50.00
+0.80 (1.63%)
At close: Jan 23, 2026
Novoprotein Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -65.02 | -54.42 | 12.84 | 90.72 | 149.01 | 83.05 | Upgrade |
Depreciation & Amortization | 31.32 | 31.32 | 22.55 | 20.46 | 9.2 | 1.67 | Upgrade |
Other Amortization | 6.11 | 6.11 | 1.58 | 1.38 | 0.78 | 0.7 | Upgrade |
Loss (Gain) From Sale of Assets | -0.14 | -0.14 | -0 | -0.04 | -0.03 | - | Upgrade |
Asset Writedown & Restructuring Costs | 6.7 | 6.7 | 0.09 | 0.08 | 0.15 | -0.11 | Upgrade |
Loss (Gain) From Sale of Investments | -2.76 | -2.76 | -17.19 | -4.16 | -0.85 | -0.11 | Upgrade |
Provision & Write-off of Bad Debts | 2.09 | 2.09 | -1.58 | 1.22 | 3.9 | 1.03 | Upgrade |
Other Operating Activities | -22.26 | 4.48 | 36.9 | 19.63 | 15.17 | 8.56 | Upgrade |
Change in Accounts Receivable | 14.64 | 14.64 | 62.8 | -57.73 | -52.73 | -24.72 | Upgrade |
Change in Inventory | -14.81 | -14.81 | -41.26 | -51.84 | -30.96 | -12.43 | Upgrade |
Change in Accounts Payable | 10.76 | 10.76 | -8.62 | -15.18 | -29.11 | 41.73 | Upgrade |
Change in Other Net Operating Assets | 12.63 | 12.63 | 10.48 | 7.01 | 7 | 4.58 | Upgrade |
Operating Cash Flow | -24.03 | 13.32 | 69.16 | 3.38 | 70.97 | 97.56 | Upgrade |
Operating Cash Flow Growth | - | -80.75% | 1948.16% | -95.24% | -27.26% | - | Upgrade |
Capital Expenditures | -41.75 | -44.88 | -44.94 | -36.77 | -69.95 | -11.8 | Upgrade |
Sale of Property, Plant & Equipment | 0 | 0 | 0.01 | 0.01 | 0 | 0 | Upgrade |
Investment in Securities | 184.85 | -129.34 | -56.6 | -963.3 | 25 | -25 | Upgrade |
Other Investing Activities | 35.04 | 16.15 | 20.11 | 0.6 | 1 | 0.11 | Upgrade |
Investing Cash Flow | 178.13 | -158.06 | -81.42 | -999.45 | -43.95 | -36.69 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 13 | Upgrade |
Total Debt Issued | - | - | - | - | - | 13 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -17 | Upgrade |
Long-Term Debt Repaid | - | -26.5 | -17.32 | -11.34 | -4.85 | - | Upgrade |
Total Debt Repaid | -26.5 | -26.5 | -17.32 | -11.34 | -4.85 | -17 | Upgrade |
Net Debt Issued (Repaid) | -26.5 | -26.5 | -17.32 | -11.34 | -4.85 | -4 | Upgrade |
Issuance of Common Stock | - | - | - | 1,742 | 117.67 | 20 | Upgrade |
Repurchase of Common Stock | -10.35 | -10.35 | - | - | - | - | Upgrade |
Common Dividends Paid | - | -35.09 | -35.09 | - | -16.29 | -1.03 | Upgrade |
Other Financing Activities | 12.68 | -0.63 | -1.52 | 2.51 | -2 | -9.61 | Upgrade |
Financing Cash Flow | -24.17 | -72.56 | -53.93 | 1,733 | 94.53 | 5.37 | Upgrade |
Foreign Exchange Rate Adjustments | 0.51 | 0.62 | 0.54 | 2.64 | -0.79 | -1.89 | Upgrade |
Net Cash Flow | 130.45 | -216.69 | -65.65 | 739.94 | 120.75 | 64.35 | Upgrade |
Free Cash Flow | -65.78 | -31.57 | 24.22 | -33.39 | 1.02 | 85.76 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -98.82% | - | Upgrade |
Free Cash Flow Margin | -44.65% | -24.75% | 15.81% | -12.62% | 0.30% | 47.69% | Upgrade |
Free Cash Flow Per Share | -0.94 | -0.45 | 0.34 | -0.58 | 0.03 | 5.40 | Upgrade |
Cash Income Tax Paid | 10.54 | 15.27 | 2.63 | 58.63 | 71.24 | 21.79 | Upgrade |
Levered Free Cash Flow | 158.99 | -21.19 | 0.36 | -68.42 | -40.11 | 52.18 | Upgrade |
Unlevered Free Cash Flow | 160.74 | -18.95 | 2.6 | -65.89 | -38.99 | 52.8 | Upgrade |
Change in Working Capital | 19.94 | 19.94 | 13.97 | -125.93 | -106.35 | 2.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.